Pyxis Oncology, Inc.·4

Mar 28, 4:31 PM ET

Wadhane Jitendra 4

4 · Pyxis Oncology, Inc. · Filed Mar 28, 2024

Insider Transaction Report

Form 4
Period: 2024-03-26
Wadhane Jitendra
SVP, Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2024-03-26+131,484398,421 total
Footnotes (1)
  • [F1]Represents restricted stock units that vest 25% on the first anniversary of March 26, 2024, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4